Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2025-09-02
DOI
https://doi.org/10.3389/fmed.2025.1658583
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review

Yanjie Liu, Shize Wang, Guoliang Shi, Maogang Gao et al.
Frontiers in Medicine
Lung Cancer Treatments and Mutations
article

Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: two case reports and literature review

Yanjie Liu, Shize Wang, Guoliang Shi, Maogang Gao, Yaqing Han, Shaonan Xie, Guangjie Liu, Qingyi Liu, K.S. Han
article en

Abstract

No abstract available for this paper.
Frontiers in MedicineVol. 12
Hebei Medical University (CN), Fourth Hospital of Hebei Medical University (CN)
Health Commission of Hebei Province
Openalex Percentile: Top 66%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.